Norway Diabetic Neuropathy Management Devices Market Size & Outlook
The diabetic neuropathy management devices market in Norway is expected to reach a projected revenue of US$ 40.0 million by 2030. A compound annual growth rate of 5.1% is expected of Norway diabetic neuropathy management devices market from 2024 to 2030.
Revenue, 2023 (US$M)
$28.2
Forecast, 2030 (US$M)
$40.0
CAGR, 2024 - 2030
5.1%
Report Coverage
Norway
Related Markets
Norway diabetic neuropathy management devices market highlights
- The Norway diabetic neuropathy management devices market generated a revenue of USD 28.2 million in 2023 and is expected to reach USD 40.0 million by 2030.
- The Norway market is expected to grow at a CAGR of 5.1% from 2024 to 2030.
- In terms of segment, neuro stimulation devices was the largest revenue generating devices in 2023.
- Electrical Stimulation Devices is the most lucrative devices segment registering the fastest growth during the forecast period.
Diabetic neuropathy management devices market data book summary
| Market revenue in 2023 | USD 28.2 million |
| Market revenue in 2030 | USD 40.0 million |
| Growth rate | 5.1% (CAGR from 2023 to 2030) |
| Largest segment | Neuro stimulation devices |
| Fastest growing segment | Electrical Stimulation Devices |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Electrical Stimulation Devices, Neuro Stimulation Devices, Nerve Conduction Testing Devices, Other Devices |
| Key market players worldwide | Medtronic PLC, Nevro Corp, NeuroMetrix Inc, Abbott Laboratories, Boston Scientific Corp, NeuroPace Inc |
Other key industry trends
- In terms of revenue, Norway accounted for 1.1% of the global diabetic neuropathy management devices market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK diabetic neuropathy management devices market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 133.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Diabetic Neuropathy Management Devices Market Scope
Diabetic neuropathy management devices market segmentation & scope
Diabetic Neuropathy Management Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| NeuroPace Inc | View profile | 181 | 455 N. Bernardo Avenue, Mountain View, CA, United States, 94043 | https://www.neuropace.com |
| Nevro Corp | View profile | 1215 | 1800 Bridge Parkway, Redwood City, CA, United States, 94065 | https://www.nevro.com |
| NeuroMetrix Inc | View profile | 26 | 4B Gill Street, Woburn, MA, United States, 01801 | https://www.neurometrix.com |
| Boston Scientific Corp | View profile | 48000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | https://www.bostonscientific.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
Norway diabetic neuropathy management devices market size, by devices, 2018-2030 (US$M)
Norway Diabetic Neuropathy Management Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
